MOGANSHAN
Mark Identification

MOGANSHAN

Serial Number

79344895

Filing Date

Jun 14, 2022

Registration Date

Mar 19, 2024

Trademark by

ZHEJIANG ZHEBEI PHARMACEUTICAL CO. LTD.

Active Trademark

Classification Information

Drugs for medical purposes, namely, adjuvant treatment of myocardial ischemia, shock, hypoxia, and tissue damage; Drugs for medical purposes, namely, antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Drugs for medical purposes, namely, antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection, in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Drugs for medical purposes, namely, anticancer preparations for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia; Drugs for medical purposes, namely, antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Antibiotics; Drugs for medical purposes, namely, adjuvant treatment of acute and chronic hepatitis; Pharmaceutical preparations, namely, adjuvant treatment of myocardial ischemia, shock, hypoxia, and tissue damage; Pharmaceutical preparations, namely, antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Pharmaceutical preparations, namely, antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection, in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Pharmaceutical preparations, namely, anticancer for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia; Pharmaceutical preparations, namely, antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Pharmaceutical preparations, namely, adjuvant treatment of acute and chronic hepatitis; Antivirals suitable for treating viral pneumonia caused by respiratory syncytial virus, bronchitis, and skin herpes virus infection in combination with interferon alpha for the treatment of chronic hepatitis C in adults; Antiallergic medicine for the treatment of seasonal rhinitis, perennial allergic rhinitis, allergic conjunctivitis and allergy-induced pruritus and urticaria; Antivirals for the treatment of acute zoster, incipient and recurrent genital herpes, and chickenpox; Anticancer preparations for choriocarcinoma, malignant mole, acute lymphoblastic leukemia and acute non-lymphoblastic leukemia, and acute stage of chronic granulocytic leukemia

Pharmaceuticals